NCT06833775View on ClinicalTrials.gov

Evaluation of Neoadjuvant Therapy Efficacy and Postoperative Pathological Indicators in Esophageal Cancer Using CT and Multimodal MRI

Not yet recruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

January 31, 2030

Study Completion Date

December 31, 2030

Conditions
Esophageal CancerNeoadjuvant Therapy
All Listed Sponsors
lead

Henan Cancer Hospital

OTHER_GOV